mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.8 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.8 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.009 |
0.8 |